Pyrazole compound as well as preparation method and application thereof

The preparation of pyrazole compounds with amide and ester-based structures through coupling addition reactions solves the problem of difficult access to raw materials and catalysts, and achieves efficient and economical preparation of pyrazole compounds, with a wide range of drug and pesticide application potential.

CN118955381AActive Publication Date: 2024-11-15GANNAN NORMAL UNIV
View PDF 1 Cites 0 Cited by

Patent Information

Application Number
CN202411028610.2
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-07-30
Publication Date
2024-11-15
Estimated Expiration
2044-07-30

AI Technical Summary

Technical Problem

The raw materials and catalysts for existing pyrazole compounds are difficult to obtain, which limits their application in drugs and pesticides.

Method used

By performing coupling and addition reactions on acrylamide compounds, diazoacetate, oxidizing agents, alkaline reagents and organic solvents, pyrazole compounds with amide and ester group structures are prepared, avoiding the use of metal catalysts and simplifying the Process flow.

Benefits of technology

The preparation of pyrazole compounds with high purity (98.5-99.9%) is achieved. The process is simple, the conditions are mild, the reaction efficiency is high, the raw materials are cheap and easy to obtain, and it has great market promotion value. The reaction rate is 77% in one step. .

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN118955381A_ABST
    Figure CN118955381A_ABST
Patent Text Reader

Abstract

The invention belongs to the technical field of organic synthesis, and particularly relates to a pyrazole compound as well as a preparation method and application thereof. The pyrazole compound provided by the invention has a structure as shown in a formula I; wherein R1 and R2 are independently aryl, substituted aryl or alkyl. The parent structure of the pyrazole compound contains amide and ester functional groups at the same time, and the pyrazole compound can be used as a new drug skeleton. The preparation method provided by the invention has the advantages of simple and convenient process, mild conditions, easy control, high reaction efficiency, cheap and easily available raw materials, no use of a metal catalyst, good functional group tolerance and the like, and the prepared pyrazole compound has high purity of 98.5-99.9%, and has great market promotion value. Compared with a multi-step synthesis reaction, a target product can be obtained through one-step reaction, the reaction yield reaches 77%, and the method has the advantages of being high in reaction efficiency and economical in step. # imgabs0 #
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The invention belongs to the technical field of organic synthesis, and specifically relates to a pyrazole compound and a preparation method and application thereof. Background Art

[0002] Pyrazole derivatives are an important class of compounds with a wide range of applications due to their anti-inflammatory and antibacterial activities. Pyrazole is one of the most important skeletons in drugs, and many pyrazole scaffold drugs contain pyrazole derivatives and have a wide range of biological activities. For example, celecoxib, which contains pyrazole derivatives, is a non-steroidal anti-inflammatory drug used to relieve arthritis symptoms. Due to its good biological activity and synthetic applications, the construction of pyrazole skeletons has attracted great attention in recent years.

[0003] Jie-Ping Wan et al. (Demao Chen, Liyun Zhou, Yunyun Liu, Jie-Ping Wan. Three-component synthesis of N-naphthyl pyrazoles via Rh(iii)-catalyzed cascadepyrazole annulation and Satoh-Miura benzannulation [J]. Chemical Communications, 2023, 59(27): 4036-4039.) reported the formation of pyrazoles from enaminones, arylhydrazines and alkynes under rhodium catalysis. The chemical reaction is as follows:

[0004]

[0005] However, the above-mentioned pyrazole compounds have the disadvantage that the raw materials and catalysts are not easily available. Summary of the invention

[0006] The object of the present invention is to provide a pyrazole compound and a preparation method and application thereof. The pyrazole compound provided by the present invention has both amide and ester structural units in its structure and can be used as a new drug skeleton while having the advantage of readily available raw materials.

[0007] In order to achieve the above object, the present invention provides the following technical solutions:

[0008] The present invention provides a pyrazole compound having a structure shown in Formula I:

[0009]

[0010] Wherein, R1 and R2 are independently aryl, substituted aryl or alkyl.

[0011] Preferably, the alkyl group has 2 to 6 carbon atoms;

[0012] The substituent group of the substituted aryl group includes one or more of an alkyl group, an alkoxy group, a nitro group, an ester group and a halogen group.

[0013] Preferably, it has the following structure:

[0014]

[0015]

[0016] The present invention also provides a method for preparing the pyrazole compound described in the above technical solution, comprising the following steps:

[0017] Mixing an acrylamide compound, a diazoacetate, an oxidant, an alkaline reagent and an organic solvent to carry out a coupling addition reaction to obtain the pyrazole compound;

[0018] The acrylamide compound has a structure shown in Formula II:

[0019]

[0020] The diazoacetate has a structure shown in Formula III:

[0021]

[0022] Preferably, the acrylamide compounds include N-phenylacrylamide, N-(4-methylphenyl)acrylamide, N-(4-methoxyphenyl)acrylamide, N-(4-fluorophenyl)acrylamide, N-(4-chlorophenyl)acrylamide, N-(4-bromophenyl)acrylamide, N-(4-trifluoromethylphenyl)acrylamide, 4-acrylamide ethyl benzoate, N-(3-fluorophenyl)acrylamide, N-(3-chlorophenyl)acrylamide, N-(2-methylphenyl)acrylamide, N-(2-fluorophenyl)acrylamide, N-(2-chlorophenyl)acrylamide, N-(2 acrylamide, N-(2,4-dimethylphenyl)acrylamide, N-(2,4-dimethoxyphenyl)acrylamide, N-(2,4-dichlorophenyl)acrylamide, N-(2-methoxy-4-nitrophenyl)acrylamide, N-(2,4-dichlorophenyl)acrylamide, N-(3-bromo-4-methylphenyl)acrylamide, N-(2,5-dichlorophenyl)acrylamide, N-(2,3-dimethylphenyl)acrylamide, N-(2,4,6-trimethylphenyl)acrylamide, N-cyclohexylacrylamide or N-(naphthalen-2-yl)prop-2-enamide.

[0023] Preferably, the diazoacetate includes ethyl diazoacetate, benzyl diazoacetate, phenoxyethylene glycol diazoacetate or tert-butyl diazoacetate.

[0024] Preferably, the molar ratio of the acrylamide compound to the diazoacetate is 1:1 to 1.25.

[0025] Preferably, the oxidant is 2,2,6,6-tetramethylpiperidinoxide;

[0026] The molar ratio of the acrylamide compound to the oxidant is 1:2-2.5.

[0027] Preferably, the coupling addition reaction is carried out at a temperature of 80 to 100° C. and for a time of 12 to 24 hours.

[0028] The present invention also provides the use of the pyrazole compound described in the above technical solution or the pyrazole compound obtained by the preparation method described in the above technical solution in the preparation of medicines or pesticides.

[0029] The present invention provides a pyrazole compound having a structure shown in Formula I; wherein R1 and R2 are independently aryl, substituted aryl or alkyl. The pyrazole compound provided by the present invention has a novel structure, and its parent structure has both amide and ester structural units, and can be used as a new drug skeleton.

[0030]

[0031] The preparation method provided by the present invention has the advantages of simple process, mild conditions, easy control, high reaction efficiency, cheap and easy to obtain raw materials, no use of metal catalysts, good functional group tolerance, etc., and the prepared pyrazole compounds have a high purity of 98.5-99.9%, and have great market promotion value. Compared with multi-step synthesis reactions, the present invention can obtain the target product in one-step reaction, and the reaction yield reaches 77%, which has the advantages of high reaction efficiency and step economy. DETAILED DESCRIPTION

[0032] The present invention provides a pyrazole compound having a structure shown in Formula I:

[0033]

[0034] Wherein, R1 and R2 are independently aryl, substituted aryl or alkyl.

[0035] In the present invention, unless otherwise specified, all preparation raw materials are commercially available products well known to those skilled in the art or products prepared by those skilled in the art using conventional methods.

[0036] In the present invention, the number of carbon atoms of the alkyl group is preferably 2 to 6, more preferably 4 to 6; the alkyl group is preferably ethyl, tert-butyl or cycloalkyl; the cycloalkyl group is preferably cyclohexyl.

[0037] In the present invention, the aryl group preferably includes a phenyl group or a naphthyl group.

[0038] In the present invention, the number of substituent groups of the substituted aromatic group is preferably 1 to 3, more preferably 1 to 2; the substituent groups of the substituted aromatic group are preferably one or more of alkyl, alkoxy, nitro, ester and halogen groups; the number of carbon atoms of the alkyl group is preferably 1; the alkoxy group is preferably methoxy or ethoxy; the ester group is preferably ethyl formate, methyl formate, benzyl formate, tert-butyl formate, phenoxy formate; the halogen group is preferably F-, Cl-, -CF3, Br- or I-.

[0039] In the present invention, the pyrazole compound preferably has the structure shown below:

[0040]

[0041]

[0042] The present invention also provides a method for preparing the pyrazole compound described in the above technical solution, comprising the following steps:

[0043] Mixing an acrylamide compound, a diazoacetate, an oxidant, an alkaline reagent and an organic solvent to carry out a coupling addition reaction to obtain the pyrazole compound;

[0044] The acrylamide compound has a structure shown in Formula II:

[0045]

[0046] The diazoacetate has a structure shown in Formula III:

[0047]

[0048] In the present invention, the acrylamide compounds preferably include N-phenylacrylamide, N-(4-methylphenyl)acrylamide, N-(4-methoxyphenyl)acrylamide, N-(4-fluorophenyl)acrylamide, N-(4-chlorophenyl)acrylamide, N-(4-bromophenyl)acrylamide, N-(4-trifluoromethylphenyl)acrylamide, 4-acrylamide ethyl benzoate, N-(3-fluorophenyl)acrylamide, N-(3-chlorophenyl)acrylamide, N-(2-methylphenyl)acrylamide, N-(2-fluorophenyl)acrylamide, N-(2-chlorophenyl)acrylamide, N- (2-bromophenyl)acrylamide, N-(2,4-dimethylphenyl)acrylamide, N-(2,4-dimethoxyphenyl)acrylamide, N-(2,4-dichlorophenyl)acrylamide, N-(2-methoxy-4-nitrophenyl)acrylamide, N-(2,4-dichlorophenyl)acrylamide, N-(3-bromo-4-methylphenyl)acrylamide, N-(2,5-dichlorophenyl)acrylamide, N-(2,3-dimethylphenyl)acrylamide, N-(2,4,6-trimethylphenyl)acrylamide, N-cyclohexylacrylamide or N-(naphthalen-2-yl)prop-2-enamide.

[0049] In the present invention, the diazoacetate preferably includes ethyl diazoacetate, benzyl diazoacetate, phenoxyethylene glycol diazoacetate or tert-butyl diazoacetate; the diazoacetate preferably has the structure shown below:

[0050]

[0051] In the present invention, the molar ratio of the acrylamide compound to the diazoacetate is preferably 1:1-1.25, more preferably 1:1.1-1.25.

[0052] In the present invention, the oxidant is preferably 2,2,6,6-tetramethylpiperidinyl oxide.

[0053] In the present invention, the molar ratio of the acrylamide compound to the oxidant is preferably 1:2-2.5, more preferably 1:2.2-2.5.

[0054] In the present invention, the alkaline agent preferably includes an inorganic alkaline agent and / or an organic alkaline agent; the inorganic alkaline agent preferably includes one or more of potassium phosphate, sodium carbonate and potassium carbonate, more preferably potassium phosphate and / or sodium carbonate; the organic alkaline agent preferably includes one or more of sodium ethoxide, sodium acetate and potassium tert-butoxide, more preferably sodium ethoxide.

[0055] In the present invention, the molar ratio of the acrylamide compound to the alkaline agent is preferably 1:1-2, more preferably 1:1.5-2.

[0056] In the present invention, the organic solvent preferably includes acetonitrile, tetrahydrofuran, dichloromethane, N,N-dimethylformamide, dimethyl sulfoxide or toluene, more preferably tetrahydrofuran, N,N-dimethylformamide, dimethyl sulfoxide or toluene, and most preferably N,N-dimethylformamide or toluene.

[0057] In the present invention, the usage ratio of the polar organic solvent to the acrylamide compound is preferably 1L: 0.1-0.4 mol, more preferably 1L: 0.1-0.2 mol.

[0058] The present invention has no particular limitation on the mixing process, and the materials can be mixed uniformly according to a process well known in the art.

[0059] In the present invention, the temperature of the coupling addition reaction is preferably 80-100°C, more preferably 90-100°C, and the time is preferably 12-24h, more preferably 12h; the coupling addition reaction is preferably carried out under stirring conditions. The present invention has no special limitation on the stirring rate, and the reaction can be carried out smoothly according to the process well known in the art.

[0060] After the coupling addition reaction, the present invention preferably includes purifying the obtained product system; the purification method is preferably column chromatography; the eluent used for the column chromatography is preferably a mixed solvent of petroleum ether and ethyl acetate; the volume ratio of petroleum ether and ethyl acetate in the mixed solvent is preferably 1 to 20:1, more preferably 2 to 4:1. The present invention does not have any special restrictions on the specific process of the column chromatography, and a method familiar to those skilled in the art can be used. The present invention uses petroleum ether and ethyl acetate as eluents for purification, and can obtain a target compound with high purity.

[0061] The present invention also provides the use of the pyrazole compound described in the above technical solution or the pyrazole compound obtained by the preparation method described in the above technical solution in the preparation of medicines or pesticides.

[0062] The present invention does not have any special limitation on the application process of the pyrazole compounds in the preparation of medicines or pesticides, and the application process may be carried out in a manner well known to those skilled in the art.

[0063] In order to further illustrate the present invention, the pyrazole compounds provided by the present invention and their preparation methods and applications are described in detail below in conjunction with examples, but they should not be construed as limiting the scope of protection of the present invention.

[0064] Example 1

[0065] The pyrazole compound obtained in this example has the following structure:

[0066]

[0067] 0.2mmol N-phenylacrylamide, 0.25mmol ethyl diazoacetate, 0.5mmol 2,2,6,6-tetramethylpiperidinoxide as an oxidant, 0.4mmol sodium ethoxide and 2mL toluene were added to the reaction tube, and the mixture was stirred at 100°C for 12h. After the reaction, the mixture was separated and purified by column chromatography. The volume ratio of petroleum ether to ethyl acetate in the column chromatography eluent was 4:1, and the purified target product was obtained with a yield of 77% and a purity of 99.9%.

[0068] The structure of the obtained product was characterized, and the structural characterization data are as follows:

[0069] 1 H NMR (400MHz, DMSO-d6, ppm) δ14.50 (s, 1H), 10.24 (s, 1H), 7.82 (d, J = 8.0hz, 2H), 7.32 (t, J = 7 .8hz,2H),7.06(t,J=7.4hz,1H),4.29(q,J=7.1hz,2H),3.63(s,1H),1.28(t,J=7.1hz,3H);

[0070] 13 C{ 1 H}NMR (100MHz, DMSO-d6, ppm) δ160.9,156.8,142.3,138.8,129.1,124.3,120.8,120.7,109.2,61.2,14.6;

[0071] MS(EI,70eV)m / z 259,214,167,121,93,77.

[0072] Example 2

[0073] The pyrazole compound obtained in this example has the following structure:

[0074]

[0075] 0.2mmol N-(4-methylphenyl)acrylamide, 0.25mmol ethyl diazoacetate, 0.5mmol 2,2,6,6-tetramethylpiperidinoxide as an oxidant, 0.4mmol sodium ethoxide and 2mL toluene were added to a reaction tube, and the mixture was stirred at 100°C for 12h. After the reaction, the mixture was separated and purified by column chromatography, and the volume ratio of petroleum ether to ethyl acetate in the column chromatography eluent was 4:1, to obtain the purified target product with a yield of 80% and a purity of 99.9%.

[0076] 1H NMR (400MHz, DMSO-d6, ppm) δ10.25 (s, 1H), 7.66 (d, J = 8.4hz, 2H), 7.44 (s, 1H), 7 .14(d,J=8.3hz,2H),4.30(q,J=7.1hz,2H),2.26(s,3H),1.31(t,J-7.1hz,3H);

[0077] 13 C{ 1 H}NMR(100MHz,DMSO-d6,ppm)δ161.1,158.5,143.0,140.6,136.5,133.3,129.5,120.7,109.1,61.0,20.9,14.6;

[0078] MS(EI,70eV)m / z 273,227,199,167,121,107,93.

[0079] Example 3

[0080] The pyrazole compound obtained in this example has the following structure:

[0081]

[0082] 0.2mmol N-(4-methoxyphenyl)acrylamide, 0.25mmol ethyl diazoacetate, 0.5mmol 2,2,6,6-tetramethylpiperidinoxide as an oxidant, 0.4mmol sodium ethoxide and 2mL toluene were added to a reaction tube, and the mixture was stirred at 100°C for 12h. After the reaction, the mixture was separated and purified by column chromatography, and the volume ratio of petroleum ether to ethyl acetate in the column chromatography eluent was 3:1, to obtain the purified target product with a yield of 84% and a purity of 99.9%.

[0083] The structure of the obtained product was characterized, and the structural characterization data are as follows:

[0084] 1 H NMR(400MHz,DMSO-d6,ppm)δ10.17(s,1H),7.70-7.68(m,2H),7.47(s,1H),6 .93-6.91(m,2H),4.32(q,J=7.1hz,2H),3.73(s,3H),1.31(t,J=7.1hz,3H);

[0085] 13 C{ 1H}NMR (100MHz, DMSO-d6, ppm) δ160.9,158.0,156.2,131.9,122.4,114.3,108.9,61.2,55.6,14.6;

[0086] MS(EI,70eV)m / z 289,243,200,167,123,108,95.

[0087] Example 4

[0088] The pyrazole compound obtained in this example has the following structure:

[0089]

[0090] 0.2mmol N-(4-fluorophenyl) acrylamide, 0.25mmol ethyl diazoacetate, 0.5mmol 2,2,6,6-tetramethylpiperidinoxide as an oxidant, 0.4mmol sodium ethoxide and 2mL toluene were added to a reaction tube, and the mixture was stirred at 100°C for 12h. After the reaction, the mixture was separated and purified by column chromatography, and the volume ratio of petroleum ether to ethyl acetate in the column chromatography eluent was 4:1, to obtain the purified target product with a yield of 84% and a purity of 99.9%.

[0091] The structure of the obtained product was characterized, and the structural characterization data are as follows:

[0092] 1 H NMR (400MHz, DMSO-d6, ppm) δ10.40(s,1H),7.84-7.79(m,2H),7.44(s,1H),7.18(t,J=8.9hz,2H),4.31(q,J=7.1hz,2H),1.30(t,J=7.1hz,3H);

[0093] 13 C{ 1 H}NMR(100MHz,DMSO-d6,ppm)δ160.0,159.7(d,J=223.0hz),157.6,143.2,140 .1,135.4(d,J=3.0hz),122.6(d,J=8hz),115.7(d,J=22hz),109.2,61.1,14.6;

[0094] MS(EI,70eV)m / z 277,231,203,167,139,121,111,93.

[0095] Example 5

[0096] The pyrazole compound obtained in this example has the following structure:

[0097]

[0098] 0.2mmol N-(4-chlorophenyl) acrylamide, 0.25mmol ethyl diazoacetate, 0.5mmol 2,2,6,6-tetramethylpiperidinoxide as an oxidant, 0.4mmol sodium ethoxide and 2mL toluene were added to the reaction tube, and the mixture was stirred at 100°C for 12h. After the reaction, the mixture was separated and purified by column chromatography, and the volume ratio of petroleum ether to ethyl acetate in the column chromatography eluent was 4:1, and the purified target product was obtained with a yield of 77% and a purity of 99.9%.

[0099] The structure of the obtained product was characterized, and the structural characterization data are as follows:

[0100] 1 H NMR (400MHz, DMSO-d6, ppm) δ14.54(s,1H),10.40(s,1H),7.85-7.81(m,2H),7.46-7.38(m,3H),4.32(q,J=7.1hz,2H),1.31(t,J=7.1hz,3H);

[0101] 13 C{ 1 H}NMR (100MHz, DMSO-d6, ppm) δ160.7,158.7,139.4,136.9,131.9,129.8,126.8,122.3,109.9,62.0,16.1;

[0102] MS(EI,70eV)m / z 293,247,212,167,127,121,111,93.

[0103] Example 6

[0104] The pyrazole compound obtained in this example has the following structure:

[0105]

[0106] 0.2mmol N-(4-bromophenyl) acrylamide, 0.25mmol ethyl diazoacetate, 0.5mmol 2,2,6,6-tetramethylpiperidinoxide as an oxidant, 0.4mmol sodium ethoxide and 2mL toluene were added to the reaction tube, and the mixture was stirred at 100°C for 12h. After the reaction, the mixture was separated and purified by column chromatography, and the volume ratio of petroleum ether to ethyl acetate in the column chromatography eluent was 4:1, and the purified target product was obtained with a yield of 73% and a purity of 99.9%.

[0107] The structure of the obtained product was characterized, and the structural characterization data are as follows:

[0108] 1 H NMR (400MHz, DMSO-d6, ppm) δ10.45(s,1H),7.79-7.76(m,2H),7.53-7.49(m,2H),7.44(s,1H),4.30(q,J=7.1hz,2H),1.30(t,J=7.1hz,3H);

[0109] 13 C{ 1 H}NMR (100MHz, DMSO-d6, ppm) δ165.5,163.5,148.0,144.8,143.2,136.7,127.4,120.8,114.1,65.9,19.4;

[0110] MS(EI,70eV)m / z 337,292,171,167,127,121,102,91.

[0111] Example 7

[0112] The pyrazole compound obtained in this example has the following structure:

[0113]

[0114] 0.2mmol N-(4-trifluoromethylphenyl) acrylamide, 0.25mmol ethyl diazoacetate, 0.5mmol 2,2,6,6-tetramethylpiperidinoxide as an oxidant, 0.4mmol sodium ethoxide and 2mL toluene were added to the reaction tube, and the mixture was stirred at 100°C for 12h. After the reaction, the mixture was separated and purified by column chromatography, and the volume ratio of petroleum ether to ethyl acetate in the column chromatography eluent was 4:1, and the purified target product was obtained with a yield of 85% and a purity of 99.9%.

[0115] The structure of the obtained product was characterized, and the structural characterization data are as follows:

[0116] 1 H NMR (400MHz, DMSO-d6, ppm) δ10.73 (s, 1H), 8.03 (d, J = 8.5hz, 2H), 7.68 (d, J = 8.5hz, 2H), 7.39 (s, 1H), 4.28 (q, J = 7.1hz, 3H), 1.29 (t,

[0117] J = 7.1 Hz, 3H);

[0118] 13 C{ 1 H}NMR (100MHz, DMSO-d6, ppm) δ161.4,159.8,143.6,142.9,140.8,126.3(q,J=10.0hz),124.4,123.7(d,J=30.0hz),120.4,109.7,60.8,14.6;

[0119] MS(EI,70eV)m / z 327,308,282,167,139,121,113,93.

[0120] Example 8

[0121] The pyrazole compound obtained in this example has the following structure:

[0122]

[0123] 0.2 mmol ethyl 4-acrylamidebenzoate, 0.25 mmol ethyl diazoacetate, 0.5 mmol 2,2,6,6-tetramethylpiperidinoxide as an oxidant, 0.4 mmol sodium ethoxide and 2 mL toluene were added to a reaction tube, and the mixture was stirred at 100° C. for 12 h. After the reaction, the mixture was separated and purified by column chromatography, and the volume ratio of petroleum ether to ethyl acetate in the column chromatography eluent was 3:1, to obtain the purified target product with a yield of 88% and a purity of 99.9%.

[0124] The structure of the obtained product was characterized, and the structural characterization data are as follows:

[0125] 1 H NMR (400MHz, DMSO-d6, ppm) δ10.61 (s, 1H), 7.94 (q, J = 9.0hz, 4H), 7.43 (s, 1H), 4.32-4.24 (m, 4H), 1.29 (t, J = 7.1hz, 6H);

[0126] 13 C{ 1 H}NMR(100MHz,DMSO-d6,ppm)δ165.8,161.1,159.4,143.6,143.4,140.6,130.5,125.0,119.9,109.6,61.0,60.9,14.61,14.59;

[0127] MS(EI,70eV)m / z 331,296,240,167,121,93.

[0128] Example 9

[0129] The pyrazole compound obtained in this example has the following structure:

[0130]

[0131] 0.2mmol N-(3-fluorophenyl)acrylamide, 0.25mmol ethyl diazoacetate, 0.5mmol 2,2,6,6-tetramethylpiperidinoxide as an oxidant, 0.4mmol sodium ethoxide and 2mL toluene were added to a reaction tube, and the mixture was stirred at 100°C for 12h. After the reaction, the mixture was separated and purified by column chromatography, and the volume ratio of petroleum ether to ethyl acetate in the column chromatography eluent was 4:1, to obtain the purified target product with a yield of 88% and a purity of 99.9%.

[0132] The structure of the obtained product was characterized, and the structural characterization data are as follows:

[0133] 1 H NMR (400MHz, DMSO-d6, ppm) δ10.60 (s, 1H), 7.77 (dt, J=11.8, 2.3hz, 1H), 7.60 (ddd, J=8.2, 2.0, 0.9hz, 1H), 7.41-7.33 (m, 2H), 6.91 (tdd,

[0134] J=8.5,2.6,0.9hz,1H),4.30(q,J=7.1hz,2H),1.30(t,J=7.1hz,3H);

[0135] 13 C{ 1 H}NMR (100MHz, DMSO-d6, ppm) δ160.9,158.0,156.2,131.9,122.4,114.3,108.9,61.2,55.6,14.6;

[0136] MS(EI,70eV)m / z 277,232,203,167,139,121,111,93.

[0137] Example 10

[0138] The pyrazole compound obtained in this example has the following structure:

[0139]

[0140] 0.2mmol N-(3-chlorophenyl)acrylamide, 0.25mmol ethyl diazoacetate, 0.5mmol 2,2,6,6-tetramethylpiperidinoxide as an oxidant, 0.4mmol sodium ethoxide and 2mL toluene were added to a reaction tube, and the mixture was stirred at 100°C for 12h. After the reaction, the mixture was separated and purified by column chromatography, and the volume ratio of petroleum ether to ethyl acetate in the column chromatography eluent was 4:1, to obtain the purified target product with a yield of 83% and a purity of 99.9%.

[0141] The structure of the obtained product was characterized, and the structural characterization data are as follows:

[0142] 1 H NMR (400MHz, DMSO-d6, ppm) δ10.45 (s, 1H), 7.98 (t, J = 2.0hz, 1H), 7.74-7.72 (m, 1H) ,7.45-73.4(m,2H),7.16-7.09(m,1H),4.32(q,J=7.1hz,2H),1.31(t,J=7.1hz,3H);

[0143] 13 C{ 1 H}NMR(100MHz,DMSO-d6,ppm)δ160.5,158.9,145.9,140.5,139.9,133.5,130.8,124.0,120.1,119.1,109.4,61.3,14.6;

[0144] MS(EI,70eV)m / z 293,248,185,167,127,121,111,93.

[0145] Embodiment 11

[0146] The pyrazole compound obtained in this example has the following structure:

[0147]

[0148] 0.2mmol N-(2-methylphenyl)acrylamide, 0.25mmol ethyl diazoacetate, 0.5mmol 2,2,6,6-tetramethylpiperidinoxide as an oxidant, 0.4mmol sodium ethoxide and 2mL toluene were added to a reaction tube, and the mixture was stirred at 100°C for 12h. After the reaction, the mixture was separated and purified by column chromatography, and the volume ratio of petroleum ether to ethyl acetate in the column chromatography eluent was 4:1, to obtain the purified target product with a yield of 86% and a purity of 99.9%.

[0149] The structure of the obtained product was characterized, and the structural characterization data are as follows:

[0150] 1 H NMR (400MHz, DMSO-d6, ppm) δ9.90 (s, 1H), 7.45 (d, J = 7.4hz, 2H), 7.27-7.15 (m, 3H), 4.32 (q, J = 7.1hz, 2H), 2.25 (s, 3H), 1.31 (t, J = 7.1hz, 3H);

[0151] 13 C{ 1 H}NMR(100MHz,DMSO-d6,ppm)δ160.8,158.6,140.1,136.0,133.4,130.8,126.6,126.4,126.3,109.1,61.1,18.2,14.6;

[0152] MS(EI,70eV)m / z 273,255,199,167,139,121,107,91.

[0153] Example 12

[0154] The pyrazole compound obtained in this example has the following structure:

[0155]

[0156] 0.2mmol N-(2-fluorophenyl)acrylamide, 0.25mmol ethyl diazoacetate, 0.5mmol 2,2,6,6-tetramethylpiperidinoxide as an oxidant, 0.4mmol sodium ethoxide and 2mL toluene were added to a reaction tube, and the mixture was stirred at 100°C for 12h. After the reaction, the mixture was separated and purified by column chromatography, and the volume ratio of petroleum ether to ethyl acetate in the column chromatography eluent was 4:1, to obtain the purified target product with a yield of 67% and a purity of 99.9%.

[0157] The structure of the obtained product was characterized, and the structural characterization data are as follows:

[0158] 1 H NMR (400MHz, DMSO-d6, ppm) δ10.09 (s, 1H), 7.74 (td, J = 7.7, 2.3hz, 1H), 7.40-7.19 (m, 4H), 4.31 (q, J = 7.1hz, 2H), 1.31 (t, J = 7.1hz, 3H);

[0159] 13 C{ 1H}NMR (100MHz, DMSO-d6, ppm) δ160.7, 158.9, 155.5 (d, J = 150.0hz), 143.4, 139.8, 127.0 (d, J = 8. 0hz), 126.4, 125.6 (d, J = 12.0hz), 124.9 (d, J = 4.0hz), 116.2 (d, J = 9.0hz), 109.35, 61.15, 14.60;

[0160] MS(EI,70eV)m / z 277,232,212,167,139,121,111,93.

[0161] Example 13

[0162] The pyrazole compound obtained in this example has the following structure:

[0163]

[0164] 0.2mmol N-(2-chlorophenyl)acrylamide, 0.25mmol ethyl diazoacetate, 0.5mmol 2,2,6,6-tetramethylpiperidinoxide as an oxidant, 0.4mmol sodium ethoxide and 2mL toluene were added to a reaction tube, and the mixture was stirred at 100°C for 12h. After the reaction, the mixture was separated and purified by column chromatography, and the volume ratio of petroleum ether to ethyl acetate in the column chromatography eluent was 4:1, to obtain the purified target product with a yield of 57% and a purity of 99.9%.

[0165] The structure of the obtained product was characterized, and the structural characterization data are as follows:

[0166] 1 H NMR (400MHz, DMSO-d6, ppm) δ9.95 (s, 1H), 7.92 (dd, J = 8.2, 1.6hz, 1H), 7.55 (dd, J =8.1,1.4hz,1H),7.41-7.21(m,3H),4.31(q,J=7.1hz,2H),1.31(t,J=7.1hz,3H);

[0167] 13 C{ 1 H}NMR (100MHz, DMSO-d6, ppm) δ160.4,159.0,134.8,130.0,128.2,127.0,125.8,109.3,61.2,14.6;

[0168] MS(EI,70eV)m / z 293,258,212,167,127,121,106,93.

[0169] Embodiment 14

[0170] The pyrazole compound obtained in this example has the following structure:

[0171]

[0172] 0.2mmol N-(2-bromophenyl) acrylamide, 0.25mmol ethyl diazoacetate, 0.5mmol 2,2,6,6-tetramethylpiperidinoxide as an oxidant, 0.4mmol sodium ethoxide and 2mL toluene were added to the reaction tube, and the mixture was stirred at 100°C for 12h. After the reaction, the mixture was separated and purified by column chromatography, and the volume ratio of petroleum ether to ethyl acetate in the column chromatography eluent was 4:1, and the purified target product was obtained with a yield of 67% and a purity of 99.9%.

[0173] The structure of the obtained product was characterized, and the structural characterization data are as follows:

[0174] 1 H NMR (400MHz, DMSO-d6, ppm) δ9.87 (s, 1H), 7.91 (d, J = 8.1hz, 1H), 7.70 (dd, J = 8.1, 1.4hz, 1H), 7.44-7.38(m,2H),7.16(td,J=7.7,1.7hz,1H),4.33(q,J=7.1hz,2H),1.31(t,J=7.1hz,3H);

[0175] 13 C{ 1 H}NMR (100MHz, DMSO-d6, ppm) δ160.0,158.8,144.7,138.8136.0,133.1,128.8,127.5,126.1,117.8,109.3,61.4,14.6;

[0176] MS(EI,70eV)m / z 337,292,258,171,139,121,106,91.

[0177] Embodiment 15

[0178] The pyrazole compound obtained in this example has the following structure:

[0179]

[0180] 0.2mmol N-(2,4-dimethylphenyl)acrylamide, 0.25mmol ethyl diazoacetate, 0.5mmol 2,2,6,6-tetramethylpiperidinoxide as an oxidant, 0.4mmol sodium ethoxide and 2mL toluene were added to the reaction tube, and the mixture was stirred at 100°C for 12h. After the reaction, the mixture was separated and purified by column chromatography, and the volume ratio of petroleum ether to ethyl acetate in the column chromatography eluent was 4:1, and the purified target product was obtained with a yield of 79% and a purity of 99.9%.

[0181] The structure of the obtained product was characterized, and the structural characterization data are as follows:

[0182] 1 H NMR (400MHz, DMSO-d6, ppm) δ9.87 (s, 1H), 7.43 (s, 1H), 7.30 (d, J = 7.9hz, 1H), 7.05- 6.99(m,2H),4.31(q,J=7.1hz,2H),2.26(s,3H),2.20(s,3H),1.31(t,J=7.1hz,3H);

[0183] 13 C{ 1 H}NMR(100MHz,DMSO-d6,ppm)δ161.0,158.6,143.0,140.4,135.5,133.4,133.2,131.3,127.0,126.3,109.0,61.1,20.9,18.2,14.6;

[0184] MS(EI,70eV)m / z 287,259,213,167,127,121,106,91.

[0185] Example 16

[0186] The pyrazole compound obtained in this example has the following structure:

[0187]

[0188] 0.2mmol N-(2,4-dimethoxyphenyl) acrylamide, 0.25mmol ethyl diazoacetate, 0.5mmol 2,2,6,6-tetramethylpiperidinoxide as an oxidant, 0.4mmol sodium ethoxide and 2mL toluene were added to the reaction tube, and the mixture was stirred at 100°C for 12h. After the reaction, the mixture was separated and purified by column chromatography, and the volume ratio of petroleum ether to ethyl acetate in the column chromatography eluent was 2:1, and the purified target product was obtained with a yield of 66% and a purity of 99.9%.

[0189] The structure of the obtained product was characterized, and the structural characterization data are as follows:

[0190] 1 H NMR (400MHz, DMSO-d6, ppm) δ9.39 (s, 1H), 7.89 (d, J = 8.8hz, 1H), 7.29 (s, 1H), 6.67 (d, J = 2.7hz, 1H), 6.54(dd,J=8.8,2.6hz,1H),4.31(q,J=7.1hz,2H),3.85(s,3H),3.76(s,3H),1.31(t,J=7.1hz,3H);

[0191] 13 C{ 1 H}NMR(100MHz,DMSO-d6,ppm)δ160.4,158.6,157.4,151.5,139.0,123.1,120.2,108.9,104.7,99.3,61.2,56.4,55.8,14.6;

[0192] MS(EI,70eV)m / z 319,273,242,167,121,109,93.

[0193] Embodiment 17

[0194] The pyrazole compound obtained in this example has the following structure:

[0195]

[0196] 0.2mmol N-(2,4-dichlorophenyl)acrylamide, 0.25mmol ethyl diazoacetate, 0.5mmol 2,2,6,6-tetramethylpiperidinoxide as an oxidant, 0.4mmol sodium ethoxide and 2mL toluene were added to the reaction tube, and the mixture was stirred at 100°C for 12h. After the reaction, the mixture was separated and purified by column chromatography, and the volume ratio of petroleum ether to ethyl acetate in the column chromatography eluent was 4:1, and the purified target product was obtained with a yield of 68% and a purity of 99.9%.

[0197] The structure of the obtained product was characterized, and the structural characterization data are as follows:

[0198] 1 H NMR (400MHz, DMSO-d6, ppm) δ9.95 (s, 1H), 7.93 (d, J = 8.8hz, 1H), 7.69 (d, J =2.4hz,1H),7.46-35(m,2H),4.31(q,J=7.1hz,2H),1.31(t,J=7.0hz,3H);

[0199] 13 C{ 1 H}NMR(100MHz,DMSO-d6,ppm)δ160.1,159.0,144.2,138.8,133.9,130.1,129.4,128.3,128.0,126.8,109.4,61.4,14.6;

[0200] MS(EI,70eV)m / z 327,292,246,167,139,121,109,93.

[0201] Embodiment 18

[0202] The pyrazole compound obtained in this example has the following structure:

[0203]

[0204] 0.2mmol N-(2-methoxy-4-nitrophenyl)acrylamide, 0.25mmol ethyl diazoacetate, 0.5mmol 2,2,6,6-tetramethylpiperidinoxide as an oxidant, 0.4mmol sodium ethoxide and 2mL toluene were added to a reaction tube, and the mixture was stirred at 100°C for 12h. After the reaction, the mixture was separated and purified by column chromatography, and the volume ratio of petroleum ether to ethyl acetate in the column chromatography eluent was 2:1, to obtain the purified target product with a yield of 80% and a purity of 99.9%.

[0205] The structure of the obtained product was characterized, and the structural characterization data are as follows:

[0206] 11 H NMR (400MHz, DMSO-d6, ppm) δ9.66 (s, 1H), 8.49 (d, J = 9.0hz, 1H), 7.92-7.79 (m ,2H),7.19(s,1H),4.31(q,J=7.1hz,2H),4.04(s,3H),1.31(t,J=7.1hz,3H);

[0207] 13 C{ 1 H}NMR(100MHz,DMSO-d6,ppm)δ159.9,159.5,148.3,145.8,143.0,138.2,133.9,118.4,117.7,109.3,106.2,61.3,57.2,14.5;

[0208] MS(EI,70eV)m / z 334,289,167,139,73.

[0209] Embodiment 19

[0210] The pyrazole compound obtained in this example has the following structure:

[0211]

[0212] 0.2mmol N-(2,4-dichlorophenyl) acrylamide, 0.25mmol ethyl diazoacetate, 0.5mmol 2,2,6,6-tetramethylpiperidinoxide as an oxidant, 0.4mmol sodium ethoxide and 2mL toluene were added to the reaction tube, and the mixture was stirred at 100°C for 12h. After the reaction, the mixture was separated and purified by column chromatography, and the volume ratio of petroleum ether to ethyl acetate in the column chromatography eluent was 4:1, and the purified target product was obtained with a yield of 86% and a purity of 99.9%.

[0213] The structure of the obtained product was characterized, and the structural characterization data are as follows:

[0214] 1 H NMR (400MHz, DMSO-d6, ppm) δ10.54 (s, 1H), 8.16 (d, J = 2.4hz, 1H), 7.79 (dd, J = 8.9, 2.5h z,1H),7.59(d,J=8.8hz,1H),7.44(s,1H),4.34(q,J=7.1hz,2H),1.33(t,J=7.1hz,3H);

[0215] 13 C{ 1 H}NMR (100MHz, DMSO-d6, ppm) δ171.9,161.0,143.5,139.4,139.1,131.4,131.0,125.8,121.9,120.7,109.5,61.3,14.6;

[0216] MS(EI,70eV)m / z 327,282,219,167,139,121,109,93.

[0217] Embodiment 20

[0218] The pyrazole compound obtained in this example has the following structure:

[0219]

[0220] 0.2mmol N-(3-bromo-4-methylphenyl)acrylamide, 0.25mmol ethyl diazoacetate, 0.5mmol 2,2,6,6-tetramethylpiperidinoxide as an oxidant, 0.4mmol sodium ethoxide and 2mL toluene were added to a reaction tube, and the mixture was stirred at 100°C for 12h. After the reaction, the mixture was separated and purified by column chromatography, and the volume ratio of petroleum ether to ethyl acetate in the column chromatography eluent was 4:1, to obtain the purified target product with a yield of 87% and a purity of 99.9%.

[0221] The structure of the obtained product was characterized, and the structural characterization data are as follows:

[0222] 1 H NMR (400MHz, DMSO-d6, ppm) δ10.37 (s, 1H), 7.80 (d, J = 2.5hz, 1H), 7.62-7.45 (m, 3H), 4.32 (q, J = 7.1hz, 2H), 2.33 (s, 3H), 1.32 (t, J = 7.1hz, 3H);

[0223] 13 C{ 1 H}NMR(100MHz,DMSO-d6,ppm)δ160.8,158.7,140.0,138.5,137.8,132.58,123.0,120.1,118.6,109.3,61.1,23.1,14.6;

[0224] MS(EI,70eV)m / z 351,306,185,167,139,121,104,93.

[0225] Embodiment 21

[0226] The pyrazole compound obtained in this example has the following structure:

[0227]

[0228] 0.2mmol N-(2,5-dichlorophenyl)acrylamide, 0.25mmol ethyl diazoacetate, 0.5mmol 2,2,6,6-tetramethylpiperidinoxide as an oxidant, 0.4mmol sodium ethoxide and 2mL toluene were added to the reaction tube, and the mixture was stirred at 100°C for 12h. After the reaction, the mixture was separated and purified by column chromatography, and the volume ratio of petroleum ether to ethyl acetate in the column chromatography eluent was 4:1, and the purified target product was obtained with a yield of 20% and a purity of 99.9%.

[0229] The structure of the obtained product was characterized, and the structural characterization data are as follows:

[0230] 1 H NMR (400MHz, DMSO-d6, ppm) δ9.59 (s, 1H), 8.10 (s, 1H), 7.57 (d, J = 8.2hz, 1H), 7.23-7.27 (m, 2H), 4.32 (q, J = 6.8hz, 2H), 1.32 (t, J = 6.7hz, 3H);

[0231] 13 C{ 1 H}NMR (100MHz, DMSO-d6, ppm) δ160.1,159.2,144.6,138.7,135.9,132.3,131.3,126.4,124.8,124.3,109.5,61.5,14.6;

[0232] MS(EI,70eV)m / z 327,292,246,139,121,109,93,65.

[0233] Embodiment 22

[0234] The pyrazole compound obtained in this example has the following structure:

[0235]

[0236] 0.2mmol N-(2,3-dimethylphenyl)acrylamide, 0.25mmol ethyl diazoacetate, 0.5mmol 2,2,6,6-tetramethylpiperidinoxide as an oxidant, 0.4mmol sodium ethoxide and 2mL toluene were added to the reaction tube, and the mixture was stirred at 100°C for 12h. After the reaction, the mixture was separated and purified by column chromatography, and the volume ratio of petroleum ether to ethyl acetate in the column chromatography eluent was 4:1, and the purified target product was obtained with a yield of 85% and a purity of 99.9%.

[0237] The structure of the obtained product was characterized, and the structural characterization data are as follows:

[0238] 1 H NMR (400MHz, DMSO-d6, ppm) δ10.01(s,1H),7.43(s,1H),7.24-7.07(m,3H),4.33(q,J=7.1hz,2H),2.28(s,3H),2.12(s,3H),1.33(t,J=7.1hz,3H);

[0239] 13 C{ 1H}NMR(100MHz,DMSO-d6,ppm)δ161.1,158.8,143.0,140.5,137.5,135.9,132.4,127.9,125.8,124.5,109.0,61.0,20.6,14.6,14.6;

[0240] MS(EI,70eV)m / z 287,269,199,167,139,121,106,91.

[0241] Embodiment 23

[0242] The pyrazole compound obtained in this example has the following structure:

[0243]

[0244] 0.2mmol N-(2,3-dimethylphenyl)acrylamide, 0.25mmol ethyl diazoacetate, 0.5mmol 2,2,6,6-tetramethylpiperidinoxide as an oxidant, 0.4mmol sodium ethoxide and 2mL toluene were added to the reaction tube, and the mixture was stirred at 100°C for 12h. After the reaction, the mixture was separated and purified by column chromatography, and the volume ratio of petroleum ether to ethyl acetate in the column chromatography eluent was 4:1, and the purified target product was obtained with a yield of 89% and a purity of 99.9%.

[0245] The structure of the obtained product was characterized, and the structural characterization data are as follows:

[0246] 1 H NMR (400MHz, DMSO-d6, ppm) δ9.81 (s, 1H), 7.46 (s, 1H), 6.90 (s, 2H), 4.32 (d, J = 7.1hz, 2H), 2.23 (s, 3H), 2.13 (s, 6H), 1.31 (t, J = 7.1hz, 3H);

[0247] 13 C{ 1 H}NMR (100MHz, DMSO-d6, ppm) δ171.0,161.0,158.6,140.4,136.4,135.7,132.1,128.8,108.9,61.2,20.9,18.3,14.5;

[0248] MS(EI,70eV)m / z 301,283,181,167,134,121,105,91.

[0249] Embodiment 24

[0250] The pyrazole compound obtained in this example has the following structure:

[0251]

[0252] 0.2mmol N-cyclohexylacrylamide, 0.25mmol ethyl diazoacetate, 0.5mmol 2,2,6,6-tetramethylpiperidinoxide as an oxidant, 0.4mmol sodium ethoxide and 2mL toluene were added to the reaction tube, and the mixture was stirred at 100°C for 12h. After the reaction, the mixture was separated and purified by column chromatography. The volume ratio of petroleum ether to ethyl acetate in the column chromatography eluent was 4:1, and the purified target product was obtained with a yield of 69% and a purity of 99.9%.

[0253] The structure of the obtained product was characterized, and the structural characterization data are as follows:

[0254] 1 H NMR(400MHz,DMSO-d6,ppm)δ8.96(d,J=8.1hz,1H),7.99(s,1H),4.96(q,J=7 .1hz,2H),4.41(dt,J=7.7,3.7hz,1H),2.50-2.25(m,5H),2.02-1.89(m,8H);

[0255] 13 C{ 1 H}NMR (100MHz, DMSO-d6, ppm) δ161.3,158.6,142.2,140.9,108.4,60.9,48.3,32.8,25.6,25.3,14.6;

[0256] MS(EI,70eV)m / z 265,222,184,167,127,138,121,98.

[0257] Embodiment 25

[0258] The pyrazole compound obtained in this example has the following structure:

[0259]

[0260] 0.2mmol N-(naphthalene-2-yl)prop-2-enamide, 0.25mmol ethyl diazoacetate, 0.5mmol 2,2,6,6-tetramethylpiperidinoxide as an oxidant, 0.4mmol sodium ethoxide and 2mL toluene were added to a reaction tube, and the mixture was stirred at 100°C for 12h. After the reaction, the mixture was separated and purified by column chromatography, and the volume ratio of petroleum ether to ethyl acetate in the column chromatography eluent was 4:1, to obtain the purified target product with a yield of 80% and a purity of 99.9%;

[0261] The structure of the obtained product was characterized, and the structural characterization data are as follows:

[0262] 1 H NMR (400MHz, DMSO-d6, ppm) δ10.49 (s, 1H), 8.46 (s, 1H), 7.91-7.84 (m, 4H), 7.55-7.40 (m, 3H), 4.34 (q, J = 7.1hz, 2H), 1.33 (t, J = 7.1hz, 3H);

[0263] 13 C{ 1 H}NMR(100MHz,DMSO-d6,ppm)δ160.7,158.7,136.6,133.7,130.5,128.8,127.9,127.9,126.9,125.4,121.2,117.1,109.3,61.2,14.6;

[0264] MS(EI,70eV)m / z 309,263,235,167,143,121,93,65.

[0265] Embodiment 26

[0266] The pyrazole compound obtained in this example has the following structure:

[0267]

[0268] 0.2mmol N-(phenyl)acrylamide, 0.25mmol tert-butyl diazoacetate, 0.5mmol 2,2,6,6-tetramethylpiperidinoxide as an oxidant, 0.4mmol sodium ethoxide and 2mL toluene were added to the reaction tube, and the mixture was stirred at 100°C for 12h. After the reaction, the mixture was separated and purified by column chromatography, and the volume ratio of petroleum ether to ethyl acetate in the column chromatography eluent was 4:1, and the purified target product was obtained with a yield of 68% and a purity of 99.9%.

[0269] The structure of the obtained product was characterized, and the structural characterization data are as follows:

[0270] 1 H NMR (400MHz, DMSO-d6, ppm) δ10.27(s,1H),7.80(d,J=8.0Hz,2H),7.35(dd,J=14.5,6.8Hz,3H),7.09(t,J=7.4Hz,1H),1.54(s,9H);

[0271] 13 C{ 1 H}NMR (100MHz, DMSO-d6, ppm) δ159.9,158.8,153.8139.0,129.1,124.3,120.8,109.0,82.0,28.3;

[0272] HRMS (ESI) m / z [M+H] + Calculate for C 15 H 17 N3O3288.1343, found 288.1340.

[0273] Embodiment 27

[0274] The pyrazole compound obtained in this example has the following structure:

[0275]

[0276] 0.2mmol N-(phenyl)acrylamide, 0.25mmol benzyl diazoacetate, 0.5mmol 2,2,6,6-tetramethylpiperidinoxide as an oxidant, 0.4mmol sodium ethoxide and 2mL toluene were added to the reaction tube, and the mixture was stirred at 100°C for 12h. After the reaction, the mixture was separated and purified by column chromatography, and the volume ratio of petroleum ether to ethyl acetate in the column chromatography eluent was 4:1, and the purified target product was obtained with a yield of 78% and a purity of 99.9%.

[0277] The structure of the obtained product was characterized, and the structural characterization data are as follows:

[0278] 1 H NMR (400MHz, DMSO-d6, ppm) δ10.32 (s, 1H), 7.82-7.80 (m, 2H), 7.58 (s, 1H), 7.549-7.33 (m, 7H), 7.10 (t, J = 7.4Hz, 1H), 5.37 (s, 2H);

[0279] 13 C{ 1H}NMR (100MHz, DMSO-d6, ppm) δ160.9,158.4,142.9,141.3,140.0,136.3,129.2,129.0128.7,124.4,120.8,109.4,66.6;

[0280] MS(EI,70eV)m / z 321,215,187,121,77;

[0281] HRMS (ESI) m / z [M+H] + Calculate for C 18 H 15 N3O3322.1186, found 322.1185.

[0282] Embodiment 28

[0283] The pyrazole compound obtained in this example has the following structure:

[0284]

[0285] 0.2mmol N-(phenyl)acrylamide, 0.25mmol diazoacetic acid phenoxyethanol ester, 0.5mmol 2,2,6,6-tetramethylpiperidinoxide as an oxidant, 0.4mmol sodium ethoxide and 2mL toluene were added to the reaction tube, and the mixture was stirred at 100°C for 12h. After the reaction, the mixture was separated and purified by column chromatography, and the volume ratio of petroleum ether to ethyl acetate in the column chromatography eluent was 4:1, and the purified target product was obtained with a yield of 79% and a purity of 99.9%.

[0286] The structure of the obtained product was characterized, and the structural characterization data are as follows:

[0287] 1 H NMR (400MHz, DMSO-d6, ppm) δ13.51(s,1H),10.30(s,1H),7.79(d,J=8.1Hz,2H),7.55(s,1H),7.32(dt,J=23.5 ,8.0Hz,4H),7.11(t,J=7.4Hz,1H),6.96(dd,J=17.7,7.8Hz,3H),4.63(t,J=4.4Hz,2H),4.31(t,J=4.4Hz,2H);

[0288] 13 C{ 1H}NMR (100MHz, DMSO-d6, ppm) δ163.3,158.6,158.3,150.0,146.3,138.9,130.0,129.2,124.4,121.4,120.8,115.0,109.3,66.1,63.8;

[0289] MS(EI,70eV)m / z 351,258,214,165,121,77;

[0290] HRMS (ESI) m / z [M+H] + Calculate for C 19 H 17 N3O4352.1230, found 352.1298.

[0291] From the above examples, it can be seen that the preparation method provided by the present invention has the advantages of simple process, mild conditions, easy control, high reaction efficiency, cheap and easy to obtain raw materials, no use of metal catalysts, good functional group tolerance, etc., and the prepared pyrazole compounds have a high purity of 98.5-99.9%, which has great market promotion value. Compared with multi-step synthesis reactions, the present invention can obtain the target product in one-step reaction, and the reaction yield reaches 77%, which has the advantages of high reaction efficiency and step economy.

[0292] Although the above embodiment describes the present invention in detail, it is only a part of the embodiments of the present invention, not all of the embodiments. Other embodiments can be obtained based on this embodiment without creativity, and these embodiments all fall within the protection scope of the present invention.

Claims

1. A pyrazole compound, It is characterized in that It has the structure shown in formula I: Wherein, R1 and R2 are independently aryl, substituted aryl or alkyl.

2. The pyrazole compound according to claim 1, It is characterized in that The number of carbon atoms of the alkyl group is 2 to 6; The substituent group of the substituted aryl group includes one or more of an alkyl group, an alkoxy group, a nitro group, an ester group and a halogen group.

3. The pyrazole compound according to claim 1 or 2, It is characterized in that Has the following structure:

4. A method for preparing the pyrazole compound according to any one of claims 1 to 3, It is characterized in that The following steps are involved: Mixing an acrylamide compound, a diazoacetate, an oxidant, an alkaline reagent and an organic solvent to carry out a coupling addition reaction to obtain the pyrazole compound; The acrylamide compound has a structure shown in Formula II: The diazoacetate has a structure shown in Formula III:

5. The preparation method according to claim 4, It is characterized in that The acrylamide compounds include N-phenylacrylamide, N-(4-methylphenyl)acrylamide, N-(4-methoxyphenyl)acrylamide, N-(4-fluorophenyl)acrylamide, N-(4-chlorophenyl)acrylamide, N-(4-bromophenyl)acrylamide, N-(4-trifluoromethylphenyl)acrylamide, 4-acrylamide ethyl benzoate, N-(3-fluorophenyl)acrylamide, N-(3-chlorophenyl)acrylamide, N-(2-methylphenyl)acrylamide, N-(2-fluorophenyl)acrylamide, N-(2-chlorophenyl)acrylamide, N-(2-bromophenyl)acrylamide, acrylamide, N-(2,4-dimethylphenyl)acrylamide, N-(2,4-dimethoxyphenyl)acrylamide, N-(2,4-dichlorophenyl)acrylamide, N-(2-methoxy-4-nitrophenyl)acrylamide, N-(2,4-dichlorophenyl)acrylamide, N-(3-bromo-4-methylphenyl)acrylamide, N-(2,5-dichlorophenyl)acrylamide, N-(2,3-dimethylphenyl)acrylamide, N-(2,4,6-trimethylphenyl)acrylamide, N-cyclohexylacrylamide or N-(naphthalen-2-yl)prop-2-enamide.

6. The preparation method according to claim 4, It is characterized in that The diazoacetate includes ethyl diazoacetate, benzyl diazoacetate, phenoxyethylene glycol diazoacetate or tert-butyl diazoacetate.

7. The preparation method according to any one of claims 4 to 6, It is characterized in that The molar ratio of the acrylamide compound to the diazoacetate is 1:1-1.

25.

8. The preparation method according to claim 4, It is characterized in that The oxidant is 2,2,6,6-tetramethylpiperidinoxide; The molar ratio of the acrylamide compound to the oxidant is 1:2-2.

5.

9. The preparation method according to claim 4, It is characterized in that The temperature of the coupling addition reaction is 80-100° C. and the time is 12-24 hours.

10. Use of the pyrazole compound according to any one of claims 1 to 3 or the pyrazole compound obtained by the preparation method according to any one of claims 4 to 9 in the preparation of medicines or pesticides.

Citation Information

Patent Citations

  • Pyrazole derivatives as bromine domain inhibitors

    CN110582485A